Related references
Note: Only part of the references are listed.RLIP: An existential requirement for breast carcinogenesis
Sharad S. Singhal et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
RLIP inhibition suppresses breast-to-lung metastasis
Jyotsana Singhal et al.
CANCER LETTERS (2019)
Synergistic efficacy of RLIP inhibition and 2′-hydroxyflavanone against DMBA-induced mammary carcinogenesis in SENCAR mice
Sharad S. Singhal et al.
MOLECULAR CARCINOGENESIS (2019)
Notch signaling in breast cancer: From pathway analysis to therapy
B. Madhu Krishna et al.
CANCER LETTERS (2019)
Rlip depletion prevents spontaneous neoplasia in TP53 null mice
Sanjay Awasthi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
2 '-Hydroxyflavanone inhibits in vitro and in vivo growth of breast cancer cells by targeting RLIP76
Jyotsana Singhal et al.
MOLECULAR CARCINOGENESIS (2018)
2′-Hydroxyflavanone: A novel strategy for targeting breast cancer
Jyotsana Singhal et al.
ONCOTARGET (2017)
Breast Cancer Statistics, 2015: Convergence of Incidence Rates Between Black and White Women
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
MYC functions are specific in biological subtypes of breast cancer and confers resistance to endocrine therapy in luminal tumours
Andrew R. Green et al.
BRITISH JOURNAL OF CANCER (2016)
Enhancement of Radiation Response in Breast Cancer Stem Cells by Inhibition of Thioredoxin- and Glutathione-Dependent Metabolism
Samuel N. Rodman et al.
RADIATION RESEARCH (2016)
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
Bernard Pereira et al.
NATURE COMMUNICATIONS (2016)
Wnt/β-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance
Maryam K. Mohammed et al.
GENES & DISEASES (2016)
Inducible in vivo genome editing with CRISPR-Cas9
Lukas E. Dow et al.
NATURE BIOTECHNOLOGY (2015)
An Inducible Lentiviral Guide RNA Platform Enables the Identification of Tumor-Essential Genes and Tumor-Promoting Mutations In Vivo
Brandon J. Aubrey et al.
CELL REPORTS (2015)
Development and Applications of CRISPR-Cas9 for Genome Engineering
Patrick D. Hsu et al.
CELL (2014)
Emerging EGFR antagonists for breast cancer
Ana Lluch et al.
EXPERT OPINION ON EMERGING DRUGS (2014)
Frontiers in Radiotherapy for Early-Stage Invasive Breast Cancer
Christine M. Fisher et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells
Ophir Shalem et al.
SCIENCE (2014)
The impact of the Oncotype Dx breast cancer assay in clinical practice: a systematic review and meta-analysis
Josh J. Carlson et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
RLIP76 Protein Knockdown Attenuates Obesity Due to a High-fat Diet
Sharad S. Singhal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
RNA-Guided Human Genome Engineering via Cas9
Prashant Mali et al.
SCIENCE (2013)
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Jianjiong Gao et al.
SCIENCE SIGNALING (2013)
Genome-Based Prediction of Breast Cancer Risk in the General Population: A Modeling Study Based on Meta-Analyses of Genetic Associations
Moniek van Zitteren et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Heterogeneity in breast cancer
Kornelia Polyak
JOURNAL OF CLINICAL INVESTIGATION (2011)
Glutathione-Conjugate Transport by RLIP76 Is Required for Clathrin-Dependent Endocytosis and Chemical Carcinogenesis
Sharad S. Singhal et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Metastatic Behavior of Breast Cancer Subtypes
Hagen Kennecke et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Regression of prostate cancer xenografts by RLIP76 depletion
Sharad S. Singhal et al.
BIOCHEMICAL PHARMACOLOGY (2009)
RLIP76: A Target for Kidney Cancer Therapy
Sharad S. Singhal et al.
CANCER RESEARCH (2009)
Epithelial to mesenchymal transition and breast cancer
Eva Tomaskovic-Crook et al.
BREAST CANCER RESEARCH (2009)
RLIP76 in defense of radiation poisoning
Jyotsana Singhal et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Regression of lung and colon cancer xenografts by depleting or inhibiting RLIP76 (Ral-binding protein 1)
Sharad S. Singhal et al.
CANCER RESEARCH (2007)
The non-ABC drug transporter RLIP76 (RALBP-1) plays a major role in the mechanisms of drug resistance
Yogesh C. Awasthi et al.
CURRENT DRUG METABOLISM (2007)
Protein expression profiling in high-risk breast cancer patients treated with high-dose or conventional dose-dense chemotherapy
Raihanatou Diallo-Danebrock et al.
CLINICAL CANCER RESEARCH (2007)
Tuning silence: conditional systems for RNA interference
Maciej Wiznerowicz et al.
NATURE METHODS (2006)
Contributions of human tumor xenografts to anticancer drug development
EA Sausville et al.
CANCER RESEARCH (2006)
Regression of melanoma in a murine model by RLIP76 depletion
SS Singhal et al.
CANCER RESEARCH (2006)
Breast cancer metastasis: Markers and models
B Weigelt et al.
NATURE REVIEWS CANCER (2005)
Gene regulation by tetracyclines - Constraints of resistance regulation in bacteria shape TetR for application in eukaryotes
C Berens et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Novel function of human RLIP76: ATP-dependent transport of glutathione conjugates and doxorubicin
S Awasthi et al.
BIOCHEMISTRY (2000)
Share Paper
